当前位置:首页 - 行情中心 - 科源制药(301281) - 财务分析

科源制药

(301281)

  

流通市值:22.31亿  总市值:35.09亿
流通股本:6885.20万   总股本:1.08亿

科源制药(301281)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.23亿元,每股收益0.21元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益138324.45万元,未分配利润31313.85万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产157601.25万元,负债19276.80万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入111,204,722.41463,716,804.91330,879,995.68237,142,859.74
营业总成本93,014,492.94415,074,066.11303,707,035.89211,807,312.62
营业利润20,049,800.0468,262,611.8745,779,440.8442,467,943.12
利润总额23,647,716.4665,708,514.6742,917,141.4640,737,829.96
净利润23,067,656.4860,271,862.2539,555,461.0936,027,184.12
其他综合收益----
综合收益总额23,067,656.4860,271,862.2539,555,461.0936,027,184.12
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计680,167,116.36690,734,868.56643,859,810.97710,579,541.14
非流动资产合计895,845,377.25861,739,402.58820,808,350.76758,032,179.21
资产总计1,576,012,493.611,552,474,271.141,464,668,161.731,468,611,720.35
流动负债合计102,712,817.61119,784,825.8599,136,243.47105,760,807.24
非流动负债合计90,055,224.6673,085,908.628,054,190.2629,357,642.47
负债合计192,768,042.27192,870,734.45127,190,433.73135,118,449.71
归属于母公司股东权益合计1,382,453,759.441,358,795,634.771,336,620,591.671,332,572,437.03
股东权益合计1,383,244,451.341,359,603,536.691,337,477,7281,333,493,270.64
负债和股东权益合计1,576,012,493.611,552,474,271.141,464,668,161.731,468,611,720.35
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计80,531,337.43367,204,068.33271,653,032.95190,116,391.64
经营活动现金流出小计81,083,486.09427,719,852.28247,782,116.39172,178,593.57
经营活动产生的现金流量净额-552,148.66-60,515,783.9523,870,916.5617,937,798.07
投资活动现金流入小计179,091,865.86970,622,262.23861,878,324.86506,296,462.37
投资活动现金流出小计215,886,268.131,158,200,062.05911,548,188.84640,172,339.93
投资活动产生的现金流量净额-36,794,402.27-187,577,799.82-49,669,863.98-133,875,877.56
筹资活动现金流入小计21,005,121.4347,631,955.61,000,0001,000,000
筹资活动现金流出小计5,558,296.732,562,968.6632,487,820.7232,487,820.72
筹资活动产生的现金流量净额15,446,824.7315,068,986.94-31,487,820.72-31,487,820.72
汇率变动对现金及现金等价物的影响415,142.81585,250.5381,826.89-30,335.11
现金及现金等价物净增加额-21,484,583.39-232,439,346.33-56,904,941.25-147,456,235.32
期末现金及现金等价物余额70,257,798.5291,769,768.21267,304,173.29176,752,879.22
TOP↑